UA2

3,4-PYRROLIDINEDIOL,2-(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)-5-(HYDROXYMETHYL)-2S,3S,4R,5R

Find entries where: UA2

is present as a standalone ligand in 2 entries

Find related ligands:

Chemical Component Summary
Name	3,4-PYRROLIDINEDIOL,2-(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)-5-(HYDROXYMETHYL)-2S,3S,4R,5R
Identifiers	(2S,3S,4R,5R)-2-(4-azanyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diol
Formula	C₁₁ H₁₅ N₅ O₃
Molecular Weight	265.269
Type	NON-POLYMER
Isomeric SMILES	c1c(c2c([nH]1)c(ncn2)N)[C@H]3[C@@H]([C@@H]([C@H](N3)CO)O)O
InChI	InChI=1S/C11H15N5O3/c12-11-8-6(14-3-15-11)4(1-13-8)7-10(19)9(18)5(2-17)16-7/h1,3,5,7,9-10,13,16-19H,2H2,(H2,12,14,15)/t5-,7+,9-,10+/m1/s1
InChIKey	AMFDITJFBUXZQN-KUBHLMPHSA-N

Chemical Details
Formal Charge	0
Atom Count	34
Chiral Atom Count	4
Bond Count	36
Aromatic Bond Count	10

Drug Info: DrugBank

DrugBank ID	DB11676
Name	Galidesivir
Groups	investigational
Description	Galidesivir is an adenosine analogue that has been investigated for use against Zaire Ebolavirus.[A191451] In animal studies, galidesivir was effective in increasing the survival rates from infections caused by various pathogens, including Ebola, Marburg, Yellow Fever and Zika viruses.[L12084] _In vitro_, it displayed broad-spectrum antiviral activity against various negative- and positive-sense RNA viruses,[A191622] including coronaviruses, filoviruses, and arenaviruses.[L12039,L12084] Phase 1 clinical trials have begun to determine the safety of this drug in humans.[L12042] Because of its activity against other coronaviruses, it may be studied as a potential therapy for COVID-19.
Synonyms	Galidésivir Galidesivirum Immucillin-A Galidesivir Immucillin A
Categories	Anti-Infective Agents Antiviral Agents Carbohydrates Experimental Unapproved Treatments for COVID-19 Glycosides Heterocyclic Compounds, Fused-Ring Nucleic Acids, Nucleotides, and Nucleosides Nucleosides Purine Nucleosides Purine-Nucleoside Phosphorylase, antagonists & inhibitors Purines Ribonucleosides
CAS number	249503-25-1

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
RNA-directed RNA polymerase L	MATQHTQYPDARLSSPIVLDQCDLVTRACGLYSSYSLNPQLRNCKLPKHI...	unknown	inhibitor

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682